---
$id: https://graph.org.ai/products/commodity/51151655
$type: Product
source: UNSPSC
code: "51151655"
title: "Otenzepad"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Otenzepad

**UNSPSC Code**: 51151655
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C24H31N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OM7J0XAL0S, chemically known as 6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((2-((diethylamino)methyl)-7-piperidinyl)acetyl)- but generally known as otenzepad, which bears US NIH Compound Identifier 107867. European Medicines Agency schedules Otenzepad in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09478MIG. The term OTENZEPAD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). OTENZEPAD is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule otenzepad under HS 29333999 and SITC 51574. As of Q4 2014, OTENZEPAD remains the US FDA Preferred Term for this commodity. Otenzepad bears US NLM identifiers UMLS ID C0090085 and NCI Concept Code C75279. SMILES: O=C(N1C2C(C(=O)[NH]C3C1NCCC3)CCCC2)CN1C(CCCC1)CN(CC)CC.

